Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2018 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
| Introductiejaar | ATC-code | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| 2018 | A10BJ06 Semaglutide | 380.019 | 9.289.754 | 24.172.952 | 36.169.031 | 55.062.928 | 83.464.604 | 114.267.048 |
| A12CC06 Magnesiumlactaat | 7.352 | 9.993 | 12.176 | 16.426 | 23.676 | 15.780 | 22.264 | |
| A16AX09 Glycerolfenylbutyraat | 96.581 | 442.254 | 592.698 | 678.478 | 965.013 | 1.129.587 | 1.266.891 | |
| A16AX15 Telotristat | 28.596 | 226.893 | 307.987 | 328.794 | 391.355 | 362.038 | 476.044 | |
| D10AD53 Adapaleen combinatiepreparaten | 15.195 | 51.226 | 61.235 | 67.738 | 60.492 | 61.104 | 65.900 | |
| J02AC05 Isavuconazol | 76.468 | 834.372 | 1.024.870 | 842.773 | 1.407.427 | 1.606.435 | 2.097.053 | |
| J05AP56 Sofosbuvir met velpatasvir en voxilaprevir | 511.836 | 729.293 | 299.296 | 436.334 | 549.390 | 218.256 | 128.628 | |
| J05AP57 Glecaprevir met pibrentasvir | 10.556.182 | 9.726.278 | 7.215.992 | 7.589.241 | 6.183.556 | 5.551.871 | 5.874.900 | |
| J05AR20 Emtricitabine met tenofoviralafenamide en bictegravir | 866.363 | 15.884.773 | 24.877.471 | 28.509.178 | 34.675.768 | 37.639.158 | 40.728.384 | |
| J05AR21 Dolutegravir met rilpivirine | 131.168 | 720.199 | 1.049.393 | 1.172.505 | 1.303.937 | 1.361.282 | 1.518.671 | |
| L04AA40 Cladribine | 2.290.508 | 4.652.954 | 3.939.497 | 5.276.482 | 10.297.112 | 15.399.281 | 16.830.137 | |
| N05AX15 Cariprazine | 4.180 | 151.146 | 338.407 | 376.650 | 474.258 | 600.418 | 606.434 | |
| R03AL08 Vilanterol met umeclidiniumbromide en fluticasonfuroaat | 819.442 | 2.222.479 | 2.609.428 | 2.966.328 | 3.353.507 | 3.647.283 | 3.974.708 | |
| R03DX07 Roflumilast | 7.386 | 85.040 | 174.796 | 182.355 | 200.682 | 221.400 | 246.659 | |
| Totaal | 15.791.275 | 45.026.652 | 66.676.199 | 84.612.313 | 114.949.101 | 151.278.497 | 188.103.720 |